Quick Answer

Plasma exchange and advanced blood filtration therapies may support the body by reducing circulating inflammatory proteins, immune complexes, and metabolic waste products associated with chronic Lyme disease and post-treatment Lyme disease syndrome (PTLDS). These approaches do not cure Lyme disease and are not a replacement for conventional antibiotic therapy. However, as part of a physician-guided, personalized protocol, they may help patients manage persistent symptoms more effectively. Candidate evaluation by a licensed physician is always required.

What Patients With Chronic Lyme Disease Should Know

Chronic Lyme disease, often referred to as post-treatment Lyme disease syndrome, affects a significant number of patients who completed antibiotic treatment but still experience ongoing symptoms. These symptoms can include severe fatigue, joint and muscle pain, cognitive difficulties, and neurological changes that affect daily quality of life.

The exact mechanism behind these persistent symptoms remains an active area of research. Leading theories point to residual immune dysregulation, circulating inflammatory proteins, molecular mimicry, and an ongoing inflammatory burden that the body struggles to resolve on its own.

For many patients, conventional medicine offers limited options beyond symptom management. This reality drives patients to explore evidence-informed, supportive therapies that may help address the underlying inflammatory and immune burden without replacing their primary care plan.

Dr. Roni Moya, Immunologist at Cellular Institute evaluates patients with chronic immune and inflammatory conditions as part of a structured medical assessment. Understanding the immune picture is critical before designing any supportive protocol for patients with complex chronic conditions.

How Plasma Exchange and Blood Filtration May Work

Plasma exchange is a process that removes a portion of the patient’s plasma and replaces it with a substitute fluid. The goal is to clear circulating antibodies, immune complexes, inflammatory cytokines, and other compounds that may contribute to ongoing symptoms.

In the context of chronic Lyme disease, researchers and clinicians have explored whether removing these circulating immune mediators could reduce the inflammatory signaling that drives fatigue, pain, and neurological symptoms. Early findings are cautiously interesting, but large-scale clinical evidence specific to Lyme disease remains limited. Responsible expectations matter here.

At Cellular Institute, a related and well-tolerated approach to blood-based support involves EBOO therapy in Cancún. EBOO, which stands for Extracorporeal Blood Oxygenation and Ozonation, filters blood through an external circuit, exposes it to medical-grade ozone and oxygen, and returns it to the body. This process may support the reduction of oxidative stress and systemic inflammatory load. It shares some conceptual overlap with plasma exchange in its goal of supporting a cleaner internal environment.

The Role of Inflammation in Persistent Lyme Symptoms

Inflammation appears to be a central driver of chronic Lyme symptoms. When the immune system stays activated long after an infection, it generates inflammatory molecules that damage tissue, impair cellular function, and interfere with energy production.

Blood-based therapies that aim to reduce this circulating inflammatory burden may create a more favorable environment for the body to begin recovering. However, the effect varies significantly between patients. Factors such as duration of illness, overall immune health, prior treatment history, and co-existing conditions all influence how a patient may respond.

This is why physician-guided evaluation is not optional. It is essential. A team approach that includes immunological assessment, lab work, and a complete health history gives the protocol its clinical foundation. You can learn more about how EBOO therapy and systemic inflammation relate in our dedicated educational resource.

What Affects Quality and Safety in Blood-Based Therapies

Not all blood-based therapies carry the same level of safety or clinical rigor. Patients exploring plasma exchange or EBOO should ask specific questions before proceeding.

• Is a physician evaluating your full medical history before treatment?
• Does the clinic use medical-grade equipment with established protocols?
• Are lab values and biomarkers reviewed before and after treatment?
• Is the therapy part of a broader, personalized protocol or offered as a standalone injection?
• Can the clinic explain the rationale behind the therapy clearly and conservatively?

At Cellular Institute, every blood-based therapy session takes place under physician supervision. The medical team reviews each patient’s history, labs, and goals before recommending any intervention. Understanding how to choose a stem cell clinic in Mexico also applies directly to choosing any regenerative or advanced medicine clinic. The same standards of transparency, physician oversight, and documentation quality should guide your decision.

Who May Be a Candidate

Patients who may benefit from blood-based supportive therapies as part of a broader chronic Lyme protocol include those who meet the following general criteria. These are starting points, not guarantees.

• Confirmed prior Lyme disease diagnosis with completed antibiotic treatment
• Ongoing symptoms of fatigue, joint pain, brain fog, or neurological changes
• Elevated inflammatory markers on lab testing
• Stable enough health to tolerate a supportive intervention
• Willingness to participate in a comprehensive, multi-modal protocol
• No contraindications to blood filtration or plasma-based therapies

Candidacy always requires a formal medical evaluation. No reputable clinic should recommend advanced blood therapies without reviewing your complete health picture.

Who May Not Be a Candidate

Blood-based therapies are not appropriate for every patient. The medical team will consider exclusion criteria carefully. Patients with certain clotting disorders, active infections, severe cardiovascular conditions, or contraindications to anticoagulation may not qualify. Physician evaluation determines appropriateness for each individual case.

How Cellular Institute Approaches This

Cellular Institute does not offer plasma exchange as an isolated or standalone service. Instead, the team builds personalized, physician-guided protocols that may combine multiple evidence-informed tools based on each patient’s clinical picture.

For patients with chronic Lyme disease or PTLDS, a supportive protocol at Cellular Institute might include EBOO therapy to address oxidative stress and inflammatory burden, peptide therapy to support immune modulation and cellular recovery, advanced recovery technologies such as hyperbaric oxygen, red light therapy, and PEMF to support tissue repair and mitochondrial function, and a structured follow-up plan to monitor progress over time.

The goal is not to promise a specific outcome. The goal is to reduce the body’s inflammatory burden, support immune balance, and create better conditions for recovery under careful medical oversight.

Cellular Institute’s broader ecosystem, which includes its in-house Cellgenic biologics arm and its connection to the ISSCA physician education network, ensures that the clinical team stays current with evolving regenerative and supportive medicine research. Cellular Institute’s approach to regenerative medicine reflects a commitment to science, transparency, and patient education at every step.

Frequently Asked Questions

Is plasma exchange the same as EBOO therapy?

No, they are different procedures. Plasma exchange removes and replaces plasma to eliminate circulating antibodies and immune complexes. EBOO filters blood through an external circuit using ozone and oxygen to support detoxification and reduce oxidative stress. Both aim to support a healthier internal environment, but through different mechanisms. A physician can help determine which approach may be more appropriate for your situation.

Can blood-based therapies cure chronic Lyme disease?

No. Blood-based therapies are not a cure for chronic Lyme disease or post-treatment Lyme disease syndrome. They may support the body by reducing inflammatory burden and improving the internal environment, but they do not eliminate Borrelia infection or reverse all symptoms. Responsible expectations and physician-guided care are essential.

How many sessions might be needed?

The number of sessions varies by patient, symptom severity, lab values, and overall health. Some patients complete a short series of sessions during a treatment visit, while others may incorporate periodic sessions as part of an ongoing maintenance protocol. Your physician will recommend a plan based on your individual evaluation.

Is it safe to travel to Cancún for this type of treatment?

Many international patients travel to Cancún for advanced regenerative and supportive medicine therapies. Cellular Institute provides structured support for international patients, including coordination, physician consultations, and recovery planning. You can explore what medical tourism in Mexico involves and what to expect as part of your planning process.

Final Thoughts

Chronic Lyme disease leaves many patients searching for answers that conventional medicine has not yet fully provided. Blood-based therapies such as EBOO and plasma exchange represent an emerging area of supportive medicine that may help reduce the inflammatory burden driving persistent symptoms. They are not cures. They are tools, and their value depends entirely on how they are used within a well-designed, physician-guided protocol.

If you have been living with persistent Lyme symptoms and want to understand whether advanced blood therapies or a broader regenerative protocol might support your recovery, the next step is a medical evaluation. Our team at Cellular Institute can help you assess your candidacy, review your history, and explain what a personalized approach might look like for you.

Take the first step by scheduling a discovery call with our patient coordination team. We will listen, answer your questions honestly, and help you understand what options may be appropriate for your situation.

Medical Disclaimer

This article is for educational purposes only and does not replace medical advice, diagnosis, or treatment. Regenerative therapies are not appropriate for every patient, and outcomes vary. A licensed physician must evaluate your medical history, goals, and candidacy before any treatment can be recommended.